Skip to content
10-Q

Quarterly Report

Kestra Medical Technologies, Ltd. KMTS

0001193125-25-316210

← back to feed
Filed
Dec 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Dec 5, 2025 58.35M sh
Shares Diluted Q2 2025 · Oct 31, 2025 51.38M sh
Shares Diluted Q2 2025 · Oct 31, 2025 51.34M sh
Shares Diluted Q2 2025 · Oct 31, 2024 19.89M sh
Shares Diluted Q2 2025 · Oct 31, 2024 19.89M sh
Capex Q2 2025 · Oct 31, 2025 $15.43M
Capex Q2 2025 · Oct 31, 2024 $11.48M
Operating Cash Flow Q2 2025 · Oct 31, 2025 −$44.62M
Operating Cash Flow Q2 2025 · Oct 31, 2024 −$35.56M
Long Term Debt Q2 2025 · Oct 31, 2025 $41.87M
Long Term Debt Q2 2025 · Apr 30, 2025 $41.1M
Cash And Equivalents Q2 2025 · Oct 31, 2025 $175.42M
Cash And Equivalents Q2 2025 · Apr 30, 2025 $237.6M
Cash And Equivalents Q2 2025 · Oct 31, 2024 $76.92M
Stockholders Equity Q2 2025 · Oct 31, 2025 $164.08M
Stockholders Equity Q2 2025 · Jul 31, 2025 $184.16M
Stockholders Equity Q2 2025 · Apr 30, 2025 $205.41M
Stockholders Equity Q2 2025 · Oct 31, 2024 −$236.55M
Stockholders Equity Q2 2025 · Jul 31, 2024 −$216.47M
Stockholders Equity Q2 2025 · Apr 30, 2024 −$209.38M
Current Liabilities Q2 2025 · Oct 31, 2025 $35.76M
Current Liabilities Q2 2025 · Apr 30, 2025 $37.98M
Total Liabilities Q2 2025 · Oct 31, 2025 $82.62M
Total Liabilities Q2 2025 · Apr 30, 2025 $90.34M
Current Assets Q2 2025 · Oct 31, 2025 $195.41M
Current Assets Q2 2025 · Apr 30, 2025 $255.33M
Total Assets Q2 2025 · Oct 31, 2025 $246.7M
Total Assets Q2 2025 · Apr 30, 2025 $295.74M
Eps Diluted Q2 2025 · Oct 31, 2025 −$0.64
Eps Diluted Q2 2025 · Oct 31, 2025 −$1.14
Eps Diluted Q2 2025 · Oct 31, 2024 −$1.19
Eps Diluted Q2 2025 · Oct 31, 2024 −$2.31
Eps Basic Q2 2025 · Oct 31, 2025 −$0.64
Eps Basic Q2 2025 · Oct 31, 2025 −$1.14
Eps Basic Q2 2025 · Oct 31, 2024 −$1.19
Eps Basic Q2 2025 · Oct 31, 2024 −$2.31
Sga Expense Q2 2025 · Oct 31, 2025 $38.3M
Sga Expense Q2 2025 · Oct 31, 2025 $72.03M
Sga Expense Q2 2025 · Oct 31, 2024 $21.46M
Sga Expense Q2 2025 · Oct 31, 2024 $40.68M
Rd Expense Q2 2025 · Oct 31, 2025 $4.88M
Rd Expense Q2 2025 · Oct 31, 2025 $8.88M
Rd Expense Q2 2025 · Oct 31, 2024 $3.51M
Rd Expense Q2 2025 · Oct 31, 2024 $6.91M
Net Income Q2 2025 · Oct 31, 2025 −$32.79M
Net Income Q2 2025 · Oct 31, 2025 −$58.61M
Net Income Q2 2025 · Oct 31, 2024 −$20.37M
Net Income Q2 2025 · Oct 31, 2024 −$40.25M
Operating Income Q2 2025 · Oct 31, 2025 −$31.76M
Operating Income Q2 2025 · Oct 31, 2025 −$60.63M
Operating Income Q2 2025 · Oct 31, 2024 −$19.13M
Operating Income Q2 2025 · Oct 31, 2024 −$37.57M
Gross Profit Q2 2025 · Oct 31, 2025 $11.42M
Gross Profit Q2 2025 · Oct 31, 2025 $20.28M
Gross Profit Q2 2025 · Oct 31, 2024 $5.83M
Gross Profit Q2 2025 · Oct 31, 2024 $10.03M
Cost Of Revenue Q2 2025 · Oct 31, 2025 $11.14M
Cost Of Revenue Q2 2025 · Oct 31, 2025 $21.66M
Cost Of Revenue Q2 2025 · Oct 31, 2024 $8.88M
Cost Of Revenue Q2 2025 · Oct 31, 2024 $17.46M
Revenue Q2 2025 · Oct 31, 2025 $22.57M
Revenue Q2 2025 · Oct 31, 2025 $41.94M
Revenue Q2 2025 · Oct 31, 2024 $14.71M
Revenue Q2 2025 · Oct 31, 2024 $27.49M